Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Eric T. Wong, M.D.

Co-Author

This page shows the publications co-authored by Eric Wong and Kenneth Swanson.
Connection Strength

6.094
  1. Dexamethasone-Friend or Foe for Patients With Glioblastoma? JAMA Neurol. 2019 03 01; 76(3):247-248.
    View in: PubMed
    Score: 0.833
  2. Alternating Electric Fields Therapy for Malignant Gliomas: From Bench Observation to Clinical Reality. Prog Neurol Surg. 2018; 32:180-195.
    View in: PubMed
    Score: 0.797
  3. Everolimus shortens survival of newly diagnosed glioblastoma patients. J Neurooncol. 2018 Oct; 140(1):179-180.
    View in: PubMed
    Score: 0.795
  4. An Overview of Alternating Electric Fields Therapy (NovoTTF Therapy) for the Treatment of Malignant Glioma. Curr Neurol Neurosci Rep. 2016 Jan; 16(1):8.
    View in: PubMed
    Score: 0.669
  5. Response to: Comment on 'Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma'. Br J Cancer. 2015 Dec 01; 113(11):1633-4.
    View in: PubMed
    Score: 0.655
  6. An Evidence-Based Review of Alternating Electric Fields Therapy for Malignant Gliomas. Curr Treat Options Oncol. 2015 Aug; 16(8):40.
    View in: PubMed
    Score: 0.650
  7. Clinical benefit in recurrent glioblastoma from adjuvant NovoTTF-100A and TCCC after temozolomide and bevacizumab failure: a preliminary observation. Cancer Med. 2015 Mar; 4(3):383-91.
    View in: PubMed
    Score: 0.627
  8. The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma. J Vis Exp. 2019 04 16; (146).
    View in: PubMed
    Score: 0.210
  9. Literature Review of Spinal Cord Glioblastoma. Am J Clin Oncol. 2018 12; 41(12):1281-1287.
    View in: PubMed
    Score: 0.205
  10. Tumor treating fields therapy device for glioblastoma: physics and clinical practice considerations. Expert Rev Med Devices. 2015; 12(6):717-26.
    View in: PubMed
    Score: 0.165
  11. Tumor treating fields perturb the localization of septins and cause aberrant mitotic exit. PLoS One. 2015; 10(5):e0125269.
    View in: PubMed
    Score: 0.160
  12. Melanoma brain metastasis globally reconfigures chemokine and cytokine profiles in patient cerebrospinal fluid. Melanoma Res. 2014 Apr; 24(2):120-30.
    View in: PubMed
    Score: 0.148
  13. Response assessment of NovoTTF-100A versus best physician's choice chemotherapy in recurrent glioblastoma. Cancer Med. 2014 Jun; 3(3):592-602.
    View in: PubMed
    Score: 0.147
  14. Metabolomics of human cerebrospinal fluid identifies signatures of malignant glioma. Mol Cell Proteomics. 2012 Jun; 11(6):M111.014688.
    View in: PubMed
    Score: 0.032
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.